# Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

> **NCT01088789** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 71 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Cyclophosphamide Pill
- **BIOLOGICAL:** GVAX Pancreas Vaccine

## Key facts

- **NCT ID:** NCT01088789
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-04-20
- **Primary completion:** 2024-07-17
- **Final completion:** 2026-08
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088789, "Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01088789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*